Renalytix

Renalytix is an artificial intelligence-enabled in vitro diagnostics company focused on the clinical management of chronic kidney disease.

Its blood-based test combines biomarker analysis with machine learning to generate a five-year kidney function decline risk score in adults with type 2 diabetes and CKD stages 1 to 3b.

Renalytix serves healthcare providers across the United States and has partnered with Tempus AI to expand access through integrated electronic health record systems.